References in periodicals archive ?
Participants were derived from three independent samples: two case-control 10-year prospective follow-up studies of boys and girls with and without ADHD and one cross-sectional randomized clinical trial of lisdexamfetamine on driving performance and behavior.
Lisdexamfetamine dimesylate (LDX) is an ADHD drug which has attracted the largest volume of research in recent years.
View Report: https://www.transparencymarketresearch.com/adhd-therapeutics-market.html Treatments available for ADHD: Medication Stimulants Amphetamine Methylphenidate Dextroamphetamine Dexmethylphenidate lisdexamfetamine dimesylate o Non stimulants Atomoxetine Bupropion Guanfacine Clonidine Psychotherapy Behavior therapy Cognitive behavioral therapy Psychoeducational input Interpersonal psychotherapy Family therapy Education or training Parent management training Social skills training School-based Interventions A combination of treatments.
The National Pregnancy Registry of Psychostimulants (866-961-2388) is studying amphetamine (Adderall), dextroamphetamine (Dexedrine and Focalin), lisdexamfetamine (Vyvanse), methylphenidate (Concerta, Daytrana, Desoxyn, Ritalin), and modafinil (Provigil).
However, a post hoc analysis suggested lisdexamfetamine had a lower tolerability relative to other amphetamines, at least in children and adolescents.
Lisdexamfetamine caps - Wikimedia Commons CAIRO - 27 July 2018: Ministry of Health issued a statement on Thursday to warn against the high blood pressure and heart failure medications containing Valsartan.
If you decide to go down the medication route, there are five types licensed for the treatment of ADHD: methylphenidate, dexamfetamine, lisdexamfetamine, atomoxetine and guanfacine.
Since discontinuing his ADHD medication, lisdexamfetamine 60 mg/d, 8 months ago, he has not been completing tasks and has been distracted in his job as a limousine driver.
In 2015, the most frequently filled medications were mixed amphetamine salts, lisdexamfetamine, and methylphenidate.
Seven participants reported taking prescribed medication for mental-health-related issues, which they reported as including fluoxetine (25%), lisdexamfetamine (12.5%), aripiprazole (12.5%), lithium (12.5%), olanzapine (12.5%), methylphenidate (12.5%), and risperidone (12.5%).
Psychotropic medications used by the 99 participants include aripirazole (n =2), alprazolam (n = 5), amphetamine-dextroamphetamine (n = 9), bupropion (n = 10), buspirone (n = 1), citalopram (n = 6), clonazepam (n = 8), desvenlafaxine (n = 1), diazepam (n = 1), duloxetine (n = 7), escitalopram (n = 16), fluvoxamine (n = 1), fluoxetine (n = 4), hy- droxyzine (n = 1), lisdexamfetamine (n = 4), lorazepam (n = 6), methylphenidate (n = 5), nortriptyline (n = 2), olanzapine (n = 2), paroxetine (n = 7), trazodone (n = 5), sertraline (n = 11), and venlafaxine (n = 7).